Sirens of the Deep follows Geralt of Rivia on a one-of-a-kind adventure on land and underwater, and though it’s part of the ...
In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback